Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition

Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 35; no. 24; pp. 3151 - 3162
Main Authors Zhang, Q, Wei, T, Shim, K, Wright, K, Xu, K, Palka-Hamblin, H L, Jurkevich, A, Khare, S
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 16.06.2016
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3′ untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1 −/− and Spry2 −/− double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis.
AbstractList Abstract Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3′ untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1 −/− and Spry2 −/− double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis.
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 52415253). We investigated the mechanisms by which SPRY regulates epithelial mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were signicantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and signicantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3 untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1/ and Spry2/ double mutant mouse embryonic broblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis.
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241-5253). We investigated the mechanisms by which SPRY regulates epithelial-mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3' untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1(-/-) and Spry2(-/-) double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis.
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3′ untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1 −/− and Spry2 −/− double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis.
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241-5253). We investigated the mechanisms by which SPRY regulates epithelialmesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3' untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. [Spry1.sup.-/-] and [Spry2.sup.-/-] double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis. Oncogene (2016) 35, 3151-3162;doi: 10.1038/onc.2015.365; published online 5 October 2015
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241-5253). We investigated the mechanisms by which SPRY regulates epithelial-mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3' untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1 super(-/-) and Spry2 super(-/-) double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis.
Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241-5253). We investigated the mechanisms by which SPRY regulates epithelialmesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3' untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. [Spry1.sup.-/-] and [Spry2.sup.-/-] double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis.
Audience Academic
Author Wei, T
Jurkevich, A
Palka-Hamblin, H L
Khare, S
Zhang, Q
Xu, K
Shim, K
Wright, K
Author_xml – sequence: 1
  givenname: Q
  surname: Zhang
  fullname: Zhang, Q
  organization: Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Missouri
– sequence: 2
  givenname: T
  surname: Wei
  fullname: Wei, T
  organization: Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Missouri
– sequence: 3
  givenname: K
  surname: Shim
  fullname: Shim, K
  organization: Department of Pediatrics, Medical College of Wisconsin
– sequence: 4
  givenname: K
  surname: Wright
  fullname: Wright, K
  organization: Department of Pediatrics, Medical College of Wisconsin
– sequence: 5
  givenname: K
  surname: Xu
  fullname: Xu, K
  organization: Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Missouri
– sequence: 6
  givenname: H L
  surname: Palka-Hamblin
  fullname: Palka-Hamblin, H L
  organization: Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago
– sequence: 7
  givenname: A
  surname: Jurkevich
  fullname: Jurkevich, A
  organization: Molecular Cytology Core, University of Missouri
– sequence: 8
  givenname: S
  surname: Khare
  fullname: Khare, S
  email: khares@health.missouri.edu
  organization: Department of Internal Medicine, Section of Gastroenterology and Hepatology, University of Missouri, Harry S. Truman Memorial Veterans’ Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26434583$$D View this record in MEDLINE/PubMed
BookMark eNqFksuKFDEUhoOMOD2jO9dS4MaF1eZeKRdCM4wXGHCj65BKTnVnqErKpFrone_gG_okk7bHdkYGJItAznd-Tg7fGToJMQBCzwleEszUmxjskmIilkyKR2hBeCNrIVp-gha4FbhuKaOn6Czna4xx02L6BJ1SyRkXii1QWM27yVszVCkOUMW-ylOK23lX-VDZOMQEdi5Va4KF9PZYTTAlyNnHUMCN7_ycK5j8vIHBm-HXj58jZAh2sxtL85xMyH4u8FP0uDdDhme39zn6-v7yy8XH-urzh08Xq6vaSiLn2vWUgcO0Ex10rjPOdQpEb3nHGShCGFG87U1rFGPCSudE2-BGYmda6VqK2Tl6d8idtt0IzkIoMwx6Sn40aaej8fp-JfiNXsfvmiuBCaEl4NVtQIrftpBnPfpsYRhMgLjNmiisGiI4Zv9Hm7ZRUkolC_ryH_Q6blMom_hN0QZTwv9SazOA9qGPZUS7D9UrLmQjlGCkUMsHqHIcjN4WR3pf3u81vD402BRzTtAf10Gw3quki0p6r5IuKhX8xd0VHuE_7hSgPgDFCR_WkO585qHAG-h_2Bc
CODEN ONCNES
CitedBy_id crossref_primary_10_3389_fmed_2022_881788
crossref_primary_10_1016_j_prp_2018_09_006
crossref_primary_10_1016_j_yexcr_2019_111644
crossref_primary_10_1002_mgg3_1032
crossref_primary_10_1186_s13058_023_01683_8
crossref_primary_10_1038_s41598_019_39200_7
crossref_primary_10_1002_jcp_29170
crossref_primary_10_1007_s12029_022_00873_5
crossref_primary_10_1007_s13277_016_4790_y
crossref_primary_10_1007_s13402_023_00791_z
crossref_primary_10_3390_cells8080808
crossref_primary_10_1002_mc_23537
crossref_primary_10_1158_1541_7786_MCR_16_0083
crossref_primary_10_1158_1541_7786_MCR_22_0476
crossref_primary_10_3390_ph15070824
crossref_primary_10_1038_s41419_020_2585_y
crossref_primary_10_1016_j_omtn_2019_09_024
crossref_primary_10_3390_cancers12040800
crossref_primary_10_3892_mmr_2019_10852
crossref_primary_10_3390_cells10102632
crossref_primary_10_1186_s12943_017_0737_1
crossref_primary_10_1111_cas_13999
crossref_primary_10_3748_wjg_v25_i31_4468
crossref_primary_10_3892_ol_2018_9433
crossref_primary_10_1016_j_exer_2022_109070
crossref_primary_10_7717_peerj_10824
crossref_primary_10_1007_s00432_023_05314_9
crossref_primary_10_3390_cells11152421
crossref_primary_10_3390_ijms21155353
Cites_doi 10.1016/j.ejca.2011.03.029
10.1038/ncb2976
10.3892/etm.2011.436
10.1073/pnas.0810715105
10.1073/pnas.1302107110
10.1158/0008-5472.CAN-06-1479
10.1016/j.ydbio.2013.04.022
10.1006/dbio.2002.0597
10.7150/thno.8712
10.1038/nature03702
10.1101/gr.2845604
10.3748/wjg.14.3792
10.1210/en.2006-0299
10.1073/pnas.012025199
10.1261/rna.810208
10.1371/journal.pone.0046665
10.1016/S1476-5586(04)80047-2
10.1016/j.devcel.2005.02.009
10.1038/nature11003
10.1038/onc.2010.225
10.1038/5007
10.4161/cbt.11.1.13965
10.1038/onc.2010.264
10.1016/S0092-8674(00)80919-8
10.1051/jbio/2004198040375
10.1038/onc.2013.140
10.1038/onc.2011.562
10.1016/j.cellsig.2013.03.025
10.1016/j.ceb.2005.08.002
10.1046/j.1432-1033.2002.02921.x
10.1517/14712598.2011.542749
10.1083/jcb.201105103
10.4161/rna.8.5.16154
10.1016/j.devcel.2004.12.004
10.1152/ajpgi.00008.2006
10.1126/science.1152623
10.1016/j.ccr.2010.09.005
10.1007/s10555-014-9497-1
10.1093/nass/nrm208
ContentType Journal Article
Copyright The Author(s) 2016
COPYRIGHT 2016 Nature Publishing Group
Copyright Nature Publishing Group Jun 16, 2016
Copyright © 2016 Macmillan Publishers Limited 2016 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2016
– notice: COPYRIGHT 2016 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jun 16, 2016
– notice: Copyright © 2016 Macmillan Publishers Limited 2016 Macmillan Publishers Limited
DBID C6C
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TM
7TO
7U9
7X7
7XB
88A
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9.
LK8
M0S
M1P
M2O
M7P
MBDVC
P64
PQEST
PQQKQ
PQUKI
PRINS
Q9U
RC3
7X8
5PM
DOI 10.1038/onc.2015.365
DatabaseName SpringerOpen
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Biological Science Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
Research Library Prep
MEDLINE - Academic


MEDLINE

AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
DocumentTitleAlternate Sprouty and colorectal cancer
EISSN 1476-5594
EndPage 3162
ExternalDocumentID 4090562831
A456758531
10_1038_onc_2015_365
26434583
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: Intramural VA
  grantid: VA999999
– fundername: NCI NIH HHS
  grantid: R03 CA150081
– fundername: BLRD VA
  grantid: I01 BX000824
– fundername: NIDCD NIH HHS
  grantid: R01 DC010387
GroupedDBID ---
-Q-
0R~
123
29N
2WC
36B
39C
3V.
4.4
406
53G
5RE
70F
7X7
88A
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAWBL
AAZLF
ABAKF
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACZOJ
ADBBV
ADFRT
ADHDB
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFSHS
AGEZK
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAP
EBLON
EBS
EE.
EIOEI
EJD
ESX
F5P
FDQFY
FEDTE
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
L7B
LK8
M0L
M1P
M2O
M7P
N9A
NAO
NQJWS
NXXTH
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNT
RNTTT
SNX
SNYQT
SOHCF
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TSG
UKHRP
W2D
WH7
AAYZH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
AADWK
AAYFA
AAYJO
ABGIJ
ACBMV
ACBRV
ACBYP
ACIGE
ACTTH
ACVWB
ADMDM
ADQMX
ADYYL
AEDAW
AEFTE
AFNRJ
AGGBP
AJCLW
AJDOV
AMRJV
NYICJ
ZA5
7TM
7TO
7U9
7XB
8FD
8FK
FR3
H94
K9.
MBDVC
P64
PQEST
PQUKI
PRINS
Q9U
RC3
7X8
5PM
ABAWZ
ABDBF
B0M
EAD
EBC
EBD
EMB
EMK
EMOBN
EPL
FRP
SV3
TUS
~8M
ID FETCH-LOGICAL-c616t-df23ed02b5bebdbaddb8e5fc4b43e81131849fa9a8335c6dd5970760da96d9203
IEDL.DBID BENPR
ISSN 0950-9232
IngestDate Tue Sep 17 21:25:14 EDT 2024
Fri Aug 16 05:15:20 EDT 2024
Fri Aug 16 06:17:28 EDT 2024
Thu Oct 10 18:18:06 EDT 2024
Thu Feb 22 23:44:20 EST 2024
Fri Feb 02 04:26:09 EST 2024
Fri Aug 23 01:51:19 EDT 2024
Wed Oct 16 00:59:26 EDT 2024
Fri Oct 11 20:46:55 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 24
Language English
License This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c616t-df23ed02b5bebdbaddb8e5fc4b43e81131849fa9a8335c6dd5970760da96d9203
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1038/onc.2015.365
PMID 26434583
PQID 1797270214
PQPubID 36330
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4850112
proquest_miscellaneous_1808715403
proquest_miscellaneous_1797866686
proquest_journals_1797270214
gale_infotracmisc_A456758531
gale_infotracacademiconefile_A456758531
crossref_primary_10_1038_onc_2015_365
pubmed_primary_26434583
springer_journals_10_1038_onc_2015_365
PublicationCentury 2000
PublicationDate 2016-06-16
PublicationDateYYYYMMDD 2016-06-16
PublicationDate_xml – month: 06
  year: 2016
  text: 2016-06-16
  day: 16
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
PublicationTitle Oncogene
PublicationTitleAbbrev Oncogene
PublicationTitleAlternate Oncogene
PublicationYear 2016
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Shim, Minowada, Coling, Martin (CR38) 2005; 8
Cheng, Chan, Wang, Zhang, Sun, Wang (CR31) 2007; 67
Feng, Wu, Tsao, Chang, Lu, Yeh (CR7) 2011; 11
Yamaguchi, Wyckoff, Condeelis (CR11) 2005; 17
Buchan, Parker (CR17) 2007; 318
Natalwala, Spychal, Tselepis (CR13) 2008; 14
Li, Zhou, Rowe, Hu, Schlaepfer, Ilic (CR21) 2011; 195
Hick, Delmarcelle, Bouquet, Klotz, Copetti, Forez (CR34) 2013; 381
Acunzo, Romano, Palmieri, Lagana, Garofalo, Balatti (CR36) 2013; 110
Rhodes, Yu, Shanker, Deshpande, Varambally, Ghosh (CR8) 2004; 6
Holgren, Dougherty, Edwin, Cerasi, Taylor, Fichera (CR5) 2010; 29
Hacohen, Kramer, Sutherland, Hiromi, Krasnow (CR1) 1998; 92
Leeksma, Van Achterberg, Tsumura, Toshima, Eldering, Kroes (CR2) 2002; 269
Ordonez-Moran, Irmisch, Barbachano, Chicote, Tenbaum, Landolfi (CR6) 2014; 33
Watanabe, Kobunai, Yamamoto, Matsuda, Ishihara, Nozawa (CR10) 2011; 47
Puisieux, Brabletz, Caramel (CR12) 2014; 16
Zhao, Ren, Wang, Sun, Yu, Wang (CR18) 2014; 4
Barbachano, Ordonez-Moran, Garcia, Sanchez, Pereira, Larriba (CR9) 2010; 29
Hino, Tsuchiya, Fukao, Kiga, Okamoto, Kanai (CR25) 2008; 14
Kroepil, Fluegen, Totikov, Baldus, Vay, Schauer (CR28) 2012; 7
Barretina, Caponigro, Stransky, Venkatesan, Margolin, Kim (CR35) 2012; 483
Su, Cooke, Ching, Hakak, Walker, Wiltshire (CR3) 2002; 99
Diaz-Lopez, Moreno-Bueno, Cano (CR14) 2014; 6
Lu, Getz, Miska, Alvarez-Saavedra, Lamb, Peck (CR22) 2005; 435
Chi, Itaranta, Zhang, Vainio (CR33) 2006; 147
Barad, Meiri, Avniel, Aharonov, Barzilai, Bentwich (CR23) 2004; 14
Kumarswamy, Volkmann, Thum (CR15) 2011; 8
CR26
Tsanou, Peschos, Batistatou, Charalabopoulos, Charalabopoulos (CR29) 2008; 28
Rychahou, Kang, Gulhati, Doan, Chen, Xiao (CR32) 2008; 105
Tazawa, Kagawa, Fujiwara (CR16) 2011; 11
Khare, Holgren, Samarel (CR41) 2006; 291
Khare, Bissonnette, Wali, Skarosi, Boss, von Lintig (CR42) 1999; 276
Villagrasa, Diaz, Vinas-Castells, Peiro, Del Valle-Perez, Dave (CR19) 2012; 31
Chiang, Song, Wang, Liu, Gao, Liang (CR24) 2012; 3
Soriano (CR39) 1999; 21
Hayashi, McMahon (CR40) 2002; 244
Masoumi-Moghaddam, Amini, Morris (CR4) 2014; 33
Basson, Akbulut, Watson-Johnson, Simon, Carroll, Shakya (CR37) 2005; 8
Agarwal, Brattain, Chowdhury (CR20) 2013; 25
Pichiorri, Suh, Rocci, De Luca, Taccioli, Santhanam (CR27) 2010; 18
Grille, Bellacosa, Larue (CR30) 2004; 198
25285168 - Theranostics. 2014 Sep 19;4(12):1193-208
16675530 - Endocrinology. 2006 Aug;147(8):3777-88
19189669 - Anticancer Res. 2008 Nov-Dec;28(6A):3815-26
15068665 - Neoplasia. 2004 Jan-Feb;6(1):1-6
23603750 - Cell Signal. 2013 Aug;25(8):1711-9
15691764 - Dev Cell. 2005 Feb;8(2):229-39
20661223 - Oncogene. 2010 Sep 23;29(38):5241-53
16920701 - Am J Physiol Gastrointest Liver Physiol. 2006 Dec;291(6):G1100-12
12027893 - Eur J Biochem. 2002 May;269(10):2546-56
9458049 - Cell. 1998 Jan 23;92(2):253-63
11944939 - Dev Biol. 2002 Apr 15;244(2):305-18
16098726 - Curr Opin Cell Biol. 2005 Oct;17(5):559-64
28288131 - Oncogene. 2017 Jul 13;36(28):4088
24744103 - Cancer Metastasis Rev. 2014 Sep;33(2-3):695-720
23624922 - Oncogene. 2014 Apr 10;33(15):1975-85
22158034 - Oncogene. 2012 Sep 6;31(36):4022-33
22969930 - Exp Ther Med. 2012 Mar;3(3):560-566
15944708 - Nature. 2005 Jun 9;435(7043):834-8
11904358 - Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4465-70
18492795 - RNA. 2008 Jul;14(7):1433-42
21099344 - Cancer Biol Ther. 2011 Jan 1;11(1):111-21
22105351 - J Cell Biol. 2011 Nov 28;195(5):729-38
20543868 - Oncogene. 2010 Aug 26;29(34):4800-13
19075230 - Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20315-20
24812525 - Cancer Manag Res. 2014 Apr 25;6:205-16
23029563 - PLoS One. 2012;7(9):e46665
21712654 - RNA Biol. 2011 Sep-Oct;8(5):706-13
21531130 - Eur J Cancer. 2011 Sep;47(13):1946-54
18609701 - World J Gastroenterol. 2008 Jun 28;14(24):3792-7
18096794 - Science. 2007 Dec 21;318(5858):1877-8
18029763 - Nucleic Acids Symp Ser (Oxf). 2007;(51):415-6
23650389 - Proc Natl Acad Sci U S A. 2013 May 21;110(21):8573-8
21219233 - Expert Opin Biol Ther. 2011 Feb;11(2):145-55
15969343 - J Soc Biol. 2004;198(4):375-8
23707896 - Dev Biol. 2013 Sep 1;381(1):227-40
9916792 - Nat Genet. 1999 Jan;21(1):70-1
10198345 - Am J Physiol. 1999 Apr;276(4 Pt 1):G1005-15
22460905 - Nature. 2012 Mar 28;483(7391):603-7
15574827 - Genome Res. 2004 Dec;14(12):2486-94
15809037 - Dev Cell. 2005 Apr;8(4):553-64
17332325 - Cancer Res. 2007 Mar 1;67(5):1979-87
24875735 - Nat Cell Biol. 2014 Jun;16(6):488-94
20951946 - Cancer Cell. 2010 Oct 19;18(4):367-81
H Yamaguchi (BFonc2015365_CR11) 2005; 17
S Masoumi-Moghaddam (BFonc2015365_CR4) 2014; 33
R Kumarswamy (BFonc2015365_CR15) 2011; 8
S Khare (BFonc2015365_CR41) 2006; 291
H Tazawa (BFonc2015365_CR16) 2011; 11
HJ Zhao (BFonc2015365_CR18) 2014; 4
F Kroepil (BFonc2015365_CR28) 2012; 7
M Acunzo (BFonc2015365_CR36) 2013; 110
T Watanabe (BFonc2015365_CR10) 2011; 47
A Puisieux (BFonc2015365_CR12) 2014; 16
L Chi (BFonc2015365_CR33) 2006; 147
GZ Cheng (BFonc2015365_CR31) 2007; 67
K Shim (BFonc2015365_CR38) 2005; 8
PG Rychahou (BFonc2015365_CR32) 2008; 105
J Barretina (BFonc2015365_CR35) 2012; 483
E Tsanou (BFonc2015365_CR29) 2008; 28
P Ordonez-Moran (BFonc2015365_CR6) 2014; 33
P Villagrasa (BFonc2015365_CR19) 2012; 31
A Natalwala (BFonc2015365_CR13) 2008; 14
E Agarwal (BFonc2015365_CR20) 2013; 25
C Holgren (BFonc2015365_CR5) 2010; 29
A Barbachano (BFonc2015365_CR9) 2010; 29
AI Su (BFonc2015365_CR3) 2002; 99
N Hacohen (BFonc2015365_CR1) 1998; 92
BFonc2015365_CR26
P Soriano (BFonc2015365_CR39) 1999; 21
O Barad (BFonc2015365_CR23) 2004; 14
A Diaz-Lopez (BFonc2015365_CR14) 2014; 6
K Hino (BFonc2015365_CR25) 2008; 14
J Lu (BFonc2015365_CR22) 2005; 435
F Pichiorri (BFonc2015365_CR27) 2010; 18
XY Li (BFonc2015365_CR21) 2011; 195
DR Rhodes (BFonc2015365_CR8) 2004; 6
OC Leeksma (BFonc2015365_CR2) 2002; 269
S Hayashi (BFonc2015365_CR40) 2002; 244
S Khare (BFonc2015365_CR42) 1999; 276
MA Basson (BFonc2015365_CR37) 2005; 8
YH Feng (BFonc2015365_CR7) 2011; 11
AC Hick (BFonc2015365_CR34) 2013; 381
JR Buchan (BFonc2015365_CR17) 2007; 318
Y Chiang (BFonc2015365_CR24) 2012; 3
S Grille (BFonc2015365_CR30) 2004; 198
References_xml – volume: 47
  start-page: 1946
  year: 2011
  end-page: 1954
  ident: CR10
  article-title: Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2011.03.029
  contributor:
    fullname: Nozawa
– volume: 16
  start-page: 488
  year: 2014
  end-page: 494
  ident: CR12
  article-title: Oncogenic roles of EMT-inducing transcription factors
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb2976
  contributor:
    fullname: Caramel
– volume: 3
  start-page: 560
  year: 2012
  end-page: 566
  ident: CR24
  article-title: microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2011.436
  contributor:
    fullname: Liang
– volume: 105
  start-page: 20315
  year: 2008
  end-page: 20320
  ident: CR32
  article-title: Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0810715105
  contributor:
    fullname: Xiao
– volume: 110
  start-page: 8573
  year: 2013
  end-page: 8578
  ident: CR36
  article-title: Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1302107110
  contributor:
    fullname: Balatti
– volume: 67
  start-page: 1979
  year: 2007
  end-page: 1987
  ident: CR31
  article-title: Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-1479
  contributor:
    fullname: Wang
– volume: 381
  start-page: 227
  year: 2013
  end-page: 240
  ident: CR34
  article-title: Reciprocal epithelial:endothelial paracrine interactions during thyroid development govern follicular organization and C-cells differentiation
  publication-title: Dev Biol
  doi: 10.1016/j.ydbio.2013.04.022
  contributor:
    fullname: Forez
– volume: 244
  start-page: 305
  year: 2002
  end-page: 318
  ident: CR40
  article-title: Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse
  publication-title: Dev Biol
  doi: 10.1006/dbio.2002.0597
  contributor:
    fullname: McMahon
– volume: 4
  start-page: 1193
  year: 2014
  end-page: 1208
  ident: CR18
  article-title: MiR-194 deregulation contributes to colorectal carcinogenesis via targeting AKT2 pathway
  publication-title: Theranostics
  doi: 10.7150/thno.8712
  contributor:
    fullname: Wang
– volume: 435
  start-page: 834
  year: 2005
  end-page: 838
  ident: CR22
  article-title: MicroRNA expression profiles classify human cancers
  publication-title: Nature
  doi: 10.1038/nature03702
  contributor:
    fullname: Peck
– volume: 14
  start-page: 2486
  year: 2004
  end-page: 2494
  ident: CR23
  article-title: MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues
  publication-title: Genome Res
  doi: 10.1101/gr.2845604
  contributor:
    fullname: Bentwich
– volume: 14
  start-page: 3792
  year: 2008
  end-page: 3797
  ident: CR13
  article-title: Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.3792
  contributor:
    fullname: Tselepis
– volume: 147
  start-page: 3777
  year: 2006
  end-page: 3788
  ident: CR33
  article-title: Sprouty2 is involved in male sex organogenesis by controlling fibroblast growth factor 9-induced mesonephric cell migration to the developing testis
  publication-title: Endocrinology
  doi: 10.1210/en.2006-0299
  contributor:
    fullname: Vainio
– volume: 99
  start-page: 4465
  year: 2002
  end-page: 4470
  ident: CR3
  article-title: Large-scale analysis of the human and mouse transcriptomes
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.012025199
  contributor:
    fullname: Wiltshire
– volume: 14
  start-page: 1433
  year: 2008
  end-page: 1442
  ident: CR25
  article-title: Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation
  publication-title: RNA
  doi: 10.1261/rna.810208
  contributor:
    fullname: Kanai
– volume: 7
  start-page: e46665
  year: 2012
  ident: CR28
  article-title: Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0046665
  contributor:
    fullname: Schauer
– volume: 6
  start-page: 1
  year: 2004
  end-page: 6
  ident: CR8
  article-title: ONCOMINE: a cancer microarray database and integrated data-mining platform
  publication-title: Neoplasia
  doi: 10.1016/S1476-5586(04)80047-2
  contributor:
    fullname: Ghosh
– volume: 8
  start-page: 553
  year: 2005
  end-page: 564
  ident: CR38
  article-title: Sprouty2, a mouse deafness gene, regulates cell fate decisions in the auditory sensory epithelium by antagonizing FGF signaling
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2005.02.009
  contributor:
    fullname: Martin
– volume: 483
  start-page: 603
  year: 2012
  end-page: 607
  ident: CR35
  article-title: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
  publication-title: Nature
  doi: 10.1038/nature11003
  contributor:
    fullname: Kim
– volume: 29
  start-page: 4800
  year: 2010
  end-page: 4813
  ident: CR9
  article-title: SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity
  publication-title: Oncogene
  doi: 10.1038/onc.2010.225
  contributor:
    fullname: Larriba
– volume: 6
  start-page: 205
  year: 2014
  end-page: 216
  ident: CR14
  article-title: Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
  publication-title: Cancer Manag Res
  contributor:
    fullname: Cano
– volume: 21
  start-page: 70
  year: 1999
  end-page: 71
  ident: CR39
  article-title: Generalized lacZ expression with the ROSA26 Cre reporter strain
  publication-title: Nat Genet
  doi: 10.1038/5007
  contributor:
    fullname: Soriano
– volume: 11
  start-page: 111
  year: 2011
  end-page: 121
  ident: CR7
  article-title: Deregulated expression of sprouty2 and microRNA-21 in human colon cancer: correlation with the clinical stage of the disease
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.11.1.13965
  contributor:
    fullname: Yeh
– volume: 29
  start-page: 5241
  year: 2010
  end-page: 5253
  ident: CR5
  article-title: Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas
  publication-title: Oncogene
  doi: 10.1038/onc.2010.264
  contributor:
    fullname: Fichera
– volume: 92
  start-page: 253
  year: 1998
  end-page: 263
  ident: CR1
  article-title: sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80919-8
  contributor:
    fullname: Krasnow
– volume: 28
  start-page: 3815
  year: 2008
  end-page: 3826
  ident: CR29
  article-title: The E-cadherin adhesion molecule and colorectal cancer. A global literature approach
  publication-title: Anticancer Res
  contributor:
    fullname: Charalabopoulos
– volume: 198
  start-page: 375
  year: 2004
  end-page: 378
  ident: CR30
  article-title: [Regulation of E-cadherin by the Akt protein kinase B]
  publication-title: J Soc Biol
  doi: 10.1051/jbio/2004198040375
  contributor:
    fullname: Larue
– volume: 33
  start-page: 1975
  year: 2014
  end-page: 1985
  ident: CR6
  article-title: SPROUTY2 is a beta-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2013.140
  contributor:
    fullname: Landolfi
– volume: 31
  start-page: 4022
  year: 2012
  end-page: 4033
  ident: CR19
  article-title: Akt2 interacts with Snail1 in the E-cadherin promoter
  publication-title: Oncogene
  doi: 10.1038/onc.2011.562
  contributor:
    fullname: Dave
– volume: 25
  start-page: 1711
  year: 2013
  end-page: 1719
  ident: CR20
  article-title: Cell survival and metastasis regulation by Akt signaling in colorectal cancer
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2013.03.025
  contributor:
    fullname: Chowdhury
– volume: 17
  start-page: 559
  year: 2005
  end-page: 564
  ident: CR11
  article-title: Cell migration in tumors
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2005.08.002
  contributor:
    fullname: Condeelis
– volume: 276
  start-page: G1005
  year: 1999
  end-page: G1015
  ident: CR42
  article-title: 1,25-dihydroxyvitamin D3 but not TPA activates PLD in Caco-2 cells via pp60(c-src) and RhoA
  publication-title: Am J Physiol
  contributor:
    fullname: von Lintig
– volume: 269
  start-page: 2546
  year: 2002
  end-page: 2556
  ident: CR2
  article-title: Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1
  publication-title: Eur J Biochem
  doi: 10.1046/j.1432-1033.2002.02921.x
  contributor:
    fullname: Kroes
– volume: 11
  start-page: 145
  year: 2011
  end-page: 155
  ident: CR16
  article-title: MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors
  publication-title: Expert Opin Biol Ther
  doi: 10.1517/14712598.2011.542749
  contributor:
    fullname: Fujiwara
– volume: 195
  start-page: 729
  year: 2011
  end-page: 738
  ident: CR21
  article-title: Snail1 controls epithelial-mesenchymal lineage commitment in focal adhesion kinase-null embryonic cells
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201105103
  contributor:
    fullname: Ilic
– volume: 8
  start-page: 706
  year: 2011
  end-page: 713
  ident: CR15
  article-title: Regulation and function of miRNA-21 in health and disease
  publication-title: RNA Biol
  doi: 10.4161/rna.8.5.16154
  contributor:
    fullname: Thum
– ident: CR26
– volume: 8
  start-page: 229
  year: 2005
  end-page: 239
  ident: CR37
  article-title: Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2004.12.004
  contributor:
    fullname: Shakya
– volume: 291
  start-page: G1100
  year: 2006
  end-page: G1112
  ident: CR41
  article-title: Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00008.2006
  contributor:
    fullname: Samarel
– volume: 318
  start-page: 1877
  year: 2007
  end-page: 1878
  ident: CR17
  article-title: Molecular biology. The two faces of miRNA
  publication-title: Science
  doi: 10.1126/science.1152623
  contributor:
    fullname: Parker
– volume: 18
  start-page: 367
  year: 2010
  end-page: 381
  ident: CR27
  article-title: Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.09.005
  contributor:
    fullname: Santhanam
– volume: 33
  start-page: 695
  year: 2014
  end-page: 720
  ident: CR4
  article-title: The developing story of Sprouty and cancer
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-014-9497-1
  contributor:
    fullname: Morris
– volume: 147
  start-page: 3777
  year: 2006
  ident: BFonc2015365_CR33
  publication-title: Endocrinology
  doi: 10.1210/en.2006-0299
  contributor:
    fullname: L Chi
– volume: 291
  start-page: G1100
  year: 2006
  ident: BFonc2015365_CR41
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00008.2006
  contributor:
    fullname: S Khare
– volume: 16
  start-page: 488
  year: 2014
  ident: BFonc2015365_CR12
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb2976
  contributor:
    fullname: A Puisieux
– volume: 110
  start-page: 8573
  year: 2013
  ident: BFonc2015365_CR36
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1302107110
  contributor:
    fullname: M Acunzo
– volume: 31
  start-page: 4022
  year: 2012
  ident: BFonc2015365_CR19
  publication-title: Oncogene
  doi: 10.1038/onc.2011.562
  contributor:
    fullname: P Villagrasa
– volume: 11
  start-page: 111
  year: 2011
  ident: BFonc2015365_CR7
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.11.1.13965
  contributor:
    fullname: YH Feng
– volume: 47
  start-page: 1946
  year: 2011
  ident: BFonc2015365_CR10
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2011.03.029
  contributor:
    fullname: T Watanabe
– volume: 483
  start-page: 603
  year: 2012
  ident: BFonc2015365_CR35
  publication-title: Nature
  doi: 10.1038/nature11003
  contributor:
    fullname: J Barretina
– volume: 381
  start-page: 227
  year: 2013
  ident: BFonc2015365_CR34
  publication-title: Dev Biol
  doi: 10.1016/j.ydbio.2013.04.022
  contributor:
    fullname: AC Hick
– volume: 6
  start-page: 205
  year: 2014
  ident: BFonc2015365_CR14
  publication-title: Cancer Manag Res
  contributor:
    fullname: A Diaz-Lopez
– volume: 6
  start-page: 1
  year: 2004
  ident: BFonc2015365_CR8
  publication-title: Neoplasia
  doi: 10.1016/S1476-5586(04)80047-2
  contributor:
    fullname: DR Rhodes
– volume: 8
  start-page: 553
  year: 2005
  ident: BFonc2015365_CR38
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2005.02.009
  contributor:
    fullname: K Shim
– volume: 14
  start-page: 2486
  year: 2004
  ident: BFonc2015365_CR23
  publication-title: Genome Res
  doi: 10.1101/gr.2845604
  contributor:
    fullname: O Barad
– volume: 28
  start-page: 3815
  year: 2008
  ident: BFonc2015365_CR29
  publication-title: Anticancer Res
  contributor:
    fullname: E Tsanou
– volume: 105
  start-page: 20315
  year: 2008
  ident: BFonc2015365_CR32
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0810715105
  contributor:
    fullname: PG Rychahou
– volume: 4
  start-page: 1193
  year: 2014
  ident: BFonc2015365_CR18
  publication-title: Theranostics
  doi: 10.7150/thno.8712
  contributor:
    fullname: HJ Zhao
– volume: 244
  start-page: 305
  year: 2002
  ident: BFonc2015365_CR40
  publication-title: Dev Biol
  doi: 10.1006/dbio.2002.0597
  contributor:
    fullname: S Hayashi
– volume: 33
  start-page: 1975
  year: 2014
  ident: BFonc2015365_CR6
  publication-title: Oncogene
  doi: 10.1038/onc.2013.140
  contributor:
    fullname: P Ordonez-Moran
– volume: 29
  start-page: 5241
  year: 2010
  ident: BFonc2015365_CR5
  publication-title: Oncogene
  doi: 10.1038/onc.2010.264
  contributor:
    fullname: C Holgren
– volume: 33
  start-page: 695
  year: 2014
  ident: BFonc2015365_CR4
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-014-9497-1
  contributor:
    fullname: S Masoumi-Moghaddam
– volume: 17
  start-page: 559
  year: 2005
  ident: BFonc2015365_CR11
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/j.ceb.2005.08.002
  contributor:
    fullname: H Yamaguchi
– volume: 11
  start-page: 145
  year: 2011
  ident: BFonc2015365_CR16
  publication-title: Expert Opin Biol Ther
  doi: 10.1517/14712598.2011.542749
  contributor:
    fullname: H Tazawa
– volume: 25
  start-page: 1711
  year: 2013
  ident: BFonc2015365_CR20
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2013.03.025
  contributor:
    fullname: E Agarwal
– volume: 99
  start-page: 4465
  year: 2002
  ident: BFonc2015365_CR3
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.012025199
  contributor:
    fullname: AI Su
– volume: 21
  start-page: 70
  year: 1999
  ident: BFonc2015365_CR39
  publication-title: Nat Genet
  doi: 10.1038/5007
  contributor:
    fullname: P Soriano
– volume: 276
  start-page: G1005
  year: 1999
  ident: BFonc2015365_CR42
  publication-title: Am J Physiol
  contributor:
    fullname: S Khare
– volume: 8
  start-page: 229
  year: 2005
  ident: BFonc2015365_CR37
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2004.12.004
  contributor:
    fullname: MA Basson
– volume: 14
  start-page: 3792
  year: 2008
  ident: BFonc2015365_CR13
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.14.3792
  contributor:
    fullname: A Natalwala
– volume: 435
  start-page: 834
  year: 2005
  ident: BFonc2015365_CR22
  publication-title: Nature
  doi: 10.1038/nature03702
  contributor:
    fullname: J Lu
– volume: 8
  start-page: 706
  year: 2011
  ident: BFonc2015365_CR15
  publication-title: RNA Biol
  doi: 10.4161/rna.8.5.16154
  contributor:
    fullname: R Kumarswamy
– volume: 3
  start-page: 560
  year: 2012
  ident: BFonc2015365_CR24
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2011.436
  contributor:
    fullname: Y Chiang
– volume: 269
  start-page: 2546
  year: 2002
  ident: BFonc2015365_CR2
  publication-title: Eur J Biochem
  doi: 10.1046/j.1432-1033.2002.02921.x
  contributor:
    fullname: OC Leeksma
– ident: BFonc2015365_CR26
  doi: 10.1093/nass/nrm208
– volume: 14
  start-page: 1433
  year: 2008
  ident: BFonc2015365_CR25
  publication-title: RNA
  doi: 10.1261/rna.810208
  contributor:
    fullname: K Hino
– volume: 318
  start-page: 1877
  year: 2007
  ident: BFonc2015365_CR17
  publication-title: Science
  doi: 10.1126/science.1152623
  contributor:
    fullname: JR Buchan
– volume: 195
  start-page: 729
  year: 2011
  ident: BFonc2015365_CR21
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201105103
  contributor:
    fullname: XY Li
– volume: 18
  start-page: 367
  year: 2010
  ident: BFonc2015365_CR27
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2010.09.005
  contributor:
    fullname: F Pichiorri
– volume: 92
  start-page: 253
  year: 1998
  ident: BFonc2015365_CR1
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80919-8
  contributor:
    fullname: N Hacohen
– volume: 29
  start-page: 4800
  year: 2010
  ident: BFonc2015365_CR9
  publication-title: Oncogene
  doi: 10.1038/onc.2010.225
  contributor:
    fullname: A Barbachano
– volume: 198
  start-page: 375
  year: 2004
  ident: BFonc2015365_CR30
  publication-title: J Soc Biol
  doi: 10.1051/jbio/2004198040375
  contributor:
    fullname: S Grille
– volume: 67
  start-page: 1979
  year: 2007
  ident: BFonc2015365_CR31
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-1479
  contributor:
    fullname: GZ Cheng
– volume: 7
  start-page: e46665
  year: 2012
  ident: BFonc2015365_CR28
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0046665
  contributor:
    fullname: F Kroepil
SSID ssj0007902
Score 2.411811
Snippet Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC)...
Abstract Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 3151
SubjectTerms 631/67
Adaptor Proteins, Signal Transducing - genetics
Adaptor Proteins, Signal Transducing - metabolism
Animals
Apoptosis
Biomarkers
Cadherins - biosynthesis
Cadherins - metabolism
Cell Biology
Cellular biology
Colorectal cancer
Colorectal Neoplasms - genetics
Colorectal Neoplasms - metabolism
Colorectal Neoplasms - pathology
Development and progression
Epithelial-Mesenchymal Transition
Female
Genetic aspects
Genetic regulation
Health aspects
Human Genetics
Humans
Internal Medicine
Intracellular Signaling Peptides and Proteins - genetics
Intracellular Signaling Peptides and Proteins - metabolism
Medicine
Medicine & Public Health
Membrane Proteins - genetics
Membrane Proteins - metabolism
Membranes
Mice
Oncology
Original
original-article
Phosphoproteins - genetics
Phosphoproteins - metabolism
Plasma
Proto-Oncogene Proteins c-akt - blood
Proto-Oncogene Proteins c-akt - metabolism
Transfection
Tumor suppressor genes
Up-Regulation
SummonAdditionalLinks – databaseName: SpringerOpen
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Li9RAEC7WFR8X0dHV7K4SYdVT3CT9SOJtGFwWQU8u7K3pV5gBNxlmM4e5-R_8h_4Sq_JiM4h4CYGqzqOruvor6tEAZ0a7wsQli7TNYnRQMhmZLHWRYIidvdROlm2C7Dd5ecW_XIvrAzgbamEm8XuWn9cV9RlMxEcmxT24LxIZk-4u5GK0t1mXWYhYIY4QrqR9evv-6MnGs29-7-w_-7mRewHSdt-5eApPesAYzjsJP4MDX83gQXeE5G4GjxbDiW0zePi1D5Q_h2re7NY0_yGlD4Z1GeLz622zC1dVSI2qydAh1ZLQN59G6mZIjK2Qcbkyq-Y29Guq2_iBivr7568bqlayy90NDm5on2tTvl7A1cXn74vLqD9aIbIykU3kypR5F6dGGG8cCsyZ3IvScsOZz5MEVzovSl1oqsmy0jn0OyiG53QhXZHG7AgOq7ryryDMrMbhaeq9L7gu8MIZ19YUJWI5UZgA3g3zrtZdBw3VRr5ZrlA-iuSjUD4BfCChKFpY-P1W9_UB-BZqUaXmCPXIuWFJAKcTTpxlOyUPYlX9grxVaHcyKr1LeABvRzKNpCSzytfbjidHdy6X_-DJY3QxEeayAF52mjL-FWJLRmHoALKJDo0M1Mp7SqlWy7alN88FGto0gPeDtt359L9M1vH_Mp7AY7yVlNyWyFM4bDZb_xphVGPetKvoD2pAHD4
  priority: 102
  providerName: Springer Nature
Title Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial–mesenchymal transition
URI https://link.springer.com/article/10.1038/onc.2015.365
https://www.ncbi.nlm.nih.gov/pubmed/26434583
https://www.proquest.com/docview/1797270214
https://search.proquest.com/docview/1797866686
https://search.proquest.com/docview/1808715403
https://pubmed.ncbi.nlm.nih.gov/PMC4850112
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbptAcNQkatNL1bptQptGVOrjRAMsLNBL5KJEUaVGVdVIvqF9IVtKwLHxwX_fGViobUW5IKGZtWFndh7MC-CTFDqTfsk8oRIfHZSEezIJtRcztJ0NF5qXbYLsNb-6iX5O4on94La0aZW9TGwFta4VfSM_Q8ZJqHYqiM7n9x5NjaLoqh2hsQcHCKAw7cGPi-vffwZZnHRZh2hH-B6aMqFNffdZelZX1MEwiL8xUiwbSmlXNG_opt28yZ3gaauTLl_CC2tMuuOO-q_gialG8LQbL7kewWHeT3MbwbNfNoj-Gm7HzXpOtHEptdCtSxd_v141a3dWudTEmoQgQhUxxOL7AF30SbMVIk5nctYsXTOnmo5bZGLvjuqY1HR9h0sb0oBtMtgbuLm8-JtfeXbogqd4wBtPlyEz2g9lLI3USEotUxOXKpIRM2kQoAyIslJkgqq1FNcaPRKK7mmRcZ2FPnsL-1VdmWNwEyVweRgaY7JIZHiJWCSUzEq08uJMOvC53_Vi3vXWKNqYOEsLpE5B1CmQOg58JZIUdOTw-ZWwlQP4L9S8qhijEUhuDwscONnCxD1W2-CeqIU9qsviP2M58HEA00pKP6tMvepwUnT0Uv4ITuqj84kGMHPgqOOT4a3Q6mQUoHYg2eKgAYGafG9Dqtm0bfYdpTGK4NCBLz2vbTz6A5v17vF3fA_PEZNTslvAT2C_WazMBzSrGnkKe8kkwWuaB6f2HOFdzvN_5vInVg
link.rule.ids 230,315,786,790,891,12083,12250,21416,27955,27956,31752,31753,33299,33300,33777,33778,41153,42222,43343,43612,43838,51609,74100,74369,74657
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9swDCa2Dlt3Kbrs5bXdPGCPk1fbkmV7lyEIVmRb21ML9CboZSRAa2eJc8i_H-lHmgRDL76Q8kOkSMr8SAF80srmOixYoEwa4gYlFYFOYxskDGNnJ5QVRQOQvRTja_77JrnpfrgtOlhlbxMbQ20rQ__IT1FxUqqdiviP2d-ATo2i7Gp3hMZjeMIZ-mqqFB_dQzzSFnOIUUQYYCATd8D3kGWnVUn9C6PkGyO3suGSdg3zhmfaRU3upE4bj3R2CAddKOkPW9m_gEeuHMDT9nDJ1QD2R_1ZbgN4dtGl0F_C7bBezUgyPgEL_arw8f7Vsl7509KnFtZkApFqSB3m39fUeQ-ZLZFxMtXTeuG7GVV03KIKB3dUxWQmqzscWpP_a6Bgr-D67OfVaBx0Ry4ERkSiDmwRM2fDWCfaaYuCtDpzSWG45sxlUYQWgOeFyhXVahlhLe5HKLdnVS5sHofsNeyVVenegp8ahcPj2DmXc5XjhTOujM4LjPGSXHvwuZ91OWs7a8gmI84yidKRJB2J0vHgK4lE0oLD9zeqqxvAp1DrKjnEEJA2PSzy4HiLE-fYbJN7ocpuoS7kvVp58HFNppEEPitdtWx5MtzmZeIBnizErSeGv8yDN62erL8KY05G6WkP0i0NWjNQi-9tSjmdNK2-eZagAY49-NLr2sar_2ey3j38jR9gf3x1cS7Pf13-OYLnOEoQ7C0Sx7BXz5fuBAOsWr9vVtE_5YkmFw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEB5BEaUXBOFlKGAkHic3ttde21xQFIjKq-JApd5W-7ISqbXTxDnk3zNjr9MkQr3kMruJvTM7j8w3MwDvlTSFCksWSJ2FGKBkPFBZbIKUoe9suTS8bAGyZ_z0PPlxkV44_NPSwSp7ndgqalNr-o98iIKTUe1UlAxLB4v483XyZX4d0AQpyrS6cRp34R5aRU4Sno9v4B5Zhz9EjyIM0KmJHQg-ZPmwrqiXYZSeMDIxW-ZpX0lvWal9BOVeGrW1TpNH8NC5lf6ok4PHcMdWA7jfDZpcD-DBuJ_rNoDD3y6d_gQuR816TlzyCWTo16WP31-vmrU_q3xqZ03qEKmaRGPxeUNd9PDZChdOZ2rWLH07p-qOSxTn4IoqmvR0fYVbG7KFLSzsKZxPvv0dnwZu_EKgecSbwJQxsyaMVaqsMshUo3KbljpRCbN5FKE2SIpSFpLqtjQ3BmMTyvMZWXBTxCF7BgdVXdkX4Gda4vY4ttYWiSzwI2GJ1Koo0d9LC-XBh_7UxbzrsiHa7DjLBXJHEHcEcseDT8QSQZcPn19LV0OAv0JtrMQI3UEKgFjkwfHOSjxjvUvumSrcpV2KGxHz4N2GTDsJiFbZetWtyTHky_kta_IQw1B0hZkHzzs52bwV-p-MUtUeZDsStFlA7b53KdVs2rb9TvIUlXHswcde1rYe_T-H9fL2d3wLh3iBxK_vZz9fwRFu4oSAi_gxHDSLlX2Nvlaj3rSX6B_HqCpV
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Atypical+role+of+sprouty+in+colorectal+cancer%3A+sprouty+repression+inhibits+epithelial-mesenchymal+transition&rft.jtitle=Oncogene&rft.au=Zhang%2C+Q&rft.au=Wei%2C+T&rft.au=Shim%2C+K&rft.au=Wright%2C+K&rft.date=2016-06-16&rft.eissn=1476-5594&rft.volume=35&rft.issue=24&rft.spage=3151&rft_id=info:doi/10.1038%2Fonc.2015.365&rft_id=info%3Apmid%2F26434583&rft.externalDocID=26434583
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon